New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-ß Aggregations.
Arch Pharm (Weinheim)
; 349(5): 327-41, 2016 May.
Article
em En
| MEDLINE
| ID: mdl-27027880
ABSTRACT
Copper and zinc have been found to contribute to the burden of amyloid-ß (Aß) aggregations in neurodegenerative Alzheimer's disease (AD). Dysregulation of these metals leads to the generation of reactive oxygen species (ROS) and eventually results in oxidative damage and accumulation of the Aß peptide, which are the key elements of the disease. Aiming to pursue the discovery of new modulators for the disease, we here rationally focused on conjugating the core hydroxyquinoline of the metal-protein attenuating compound PBT2 and the N-methylanilide analogous moiety of the Aß imaging agent to build a new type of multi-target modulators of Aß aggregations. We found that the N,N-dimethylanilinyl imines 7a, 8a, and the corresponding amines 7b, 8b exerted efficient inhibition of Cu(2+) - or Zn(2+) -induced Aß aggregations and significant disassembly of metal-mediated Aß aggregated fibrils. Further, 7a and 7b also exhibited significant ROC scavenging effects compared to PBT2. The results suggested that 7a and 7b are promising lead compounds for the development of a new therapy for AD.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Peptídeos beta-Amiloides
/
Agregação Patológica de Proteínas
/
Hidroxiquinolinas
Idioma:
En
Revista:
Arch Pharm (Weinheim)
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Taiwan